Antibiotics for Patients With a Planned Re-Laparotomy for Intra-Abdominal Infection
- PMID: 38407831
- PMCID: PMC11001956
- DOI: 10.1089/sur.2023.255
Antibiotics for Patients With a Planned Re-Laparotomy for Intra-Abdominal Infection
Abstract
Background: Appropriate antimicrobial therapy for the management of intra-abdominal infection (IAI) continues to evolve based on available literature. The Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial provided evidence to support four days of antibiotic agents in IAI post-source control but excluded patients with a planned re-laparotomy. This study aimed to determine the short- and long-term recurrent infection risk in this population. Patients and Methods: This is a single-center, retrospective, observational study of adult patients admitted to a quaternary medical center between January 1, 2016, and August 1, 2022, with IAI requiring planned laparotomy. Patients were designated as receiving five or less days of antibiotic agents (short course) or more than five days (long course) after source control. The primary outcome was IAI recurrence within 30 days. Results: Of the 104 patients who met inclusion criteria, 78 were included in analysis. Average age was 57 ± 13.3 years, 56% were male, 94% Caucasian, with a mean Acute Physiology and Chronic Health Evaluation (APACHE) II score of 17 ± 7.09. All other baseline characteristics and clinical severity markers were similar between the two groups. Regarding the primary outcome of IAI recurrence, there was no difference when comparing those who received short course versus those who received long course therapy (41.2% vs. 44.4%; p = 0.781). No differences were found between groups with respect to secondary outcomes. Conclusions: In patients admitted with IAI managed with planned re-laparotomy those who received short course antimicrobial therapy were not found to have an increase in IAI recurrence compared to those with longer courses of therapy.
Keywords: antibiotic duration; antimicrobial stewardship; intra-abdominal infection; laparotomy; open abdomen; recurrence.
Conflict of interest statement
No competing financial interests exist.
Figures
Similar articles
-
Systemic and topical antibiotics for chronic rhinosinusitis.Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011994. doi: 10.1002/14651858.CD011994.pub2. Cochrane Database Syst Rev. 2016. PMID: 27113482 Free PMC article.
-
Interventions for treating genital Chlamydia trachomatis infection in pregnancy.Cochrane Database Syst Rev. 2017 Sep 22;9(9):CD010485. doi: 10.1002/14651858.CD010485.pub2. Cochrane Database Syst Rev. 2017. PMID: 28937705 Free PMC article.
-
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis.Cochrane Database Syst Rev. 2025 Jan 20;1(1):CD009730. doi: 10.1002/14651858.CD009730.pub3. Cochrane Database Syst Rev. 2025. PMID: 39831540
-
Antibiotic regimens for management of intra-amniotic infection.Cochrane Database Syst Rev. 2014 Dec 19;2014(12):CD010976. doi: 10.1002/14651858.CD010976.pub2. Cochrane Database Syst Rev. 2014. PMID: 25526426 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
-
- Riccio LM, Popovsky KA, Hranjec T, et al. . Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: A study of 2,552 consecutive infections. Surg Infect 2014;15(4):417–424; doi: 10.1089/sur.2012.077 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous